Curriculum Vitae

Prof. Dr. Jochen Seissler

Current position

W2-Professor, Head of Diabetes Center Ludwig-Maximilians-Universität München

Academic education and scientific degrees

 

Since 2006

W2-Professor, University Hospital of Ludwig-Maximilians-Universität München, Germany

2000

Habilitation (Lecturer), Venia legendi Internal Medicine

1988

Degree M.D., University of Ulm, Germany

 

Academic and research positions

 

Since 2006

Head of Diabetes Center, University Hospital of Ludwig-Maximilians-Universität München, Germany

2001

Consultant in Endocrinology

1997 - 2005

Senior Physician at the German Diabetes Center, Duesseldorf, Germany

1996

Consultant in Internal Medicine and Diabetology

1993 - 1997

Residency Internal Medicine and Endocrinology, Department of Medicine III, University of Leipzig, Germany

1989 - 1993

Clinical Associate and Fellow in Internal Medicine, Department of Medicine I, University of Ulm, Germany

 

Additional information

 

Memberships

DDG, EASD, DGE, DiabetesDE, DGErnährung, FKDB, VBI

 

 

Awards

Research prize of North-Rhine-Westfalia (Bennigsen-Foerder-Preis)
Menarini Prize of the German Diabetes Society

Reviewer for

Annals of Anatomy, Biotechnology and Applied Biochemistry, Cell Proliferation, Clinical Chemistry, Clinical and Experimental Endocrinology and Diabetes, Deutsches Ärzteblatt, Diabetes, Diabetes Metabolism Research and Reviews, Diabetic Medicine, Diabetologia, Diabetologie und Stoffwechsel, European Journal of Endocrinology, Experimental Endocrinology and Diabetes; Hormone and Metabolic Research, Münchner Medizinische Wochenschrift, Journal of Pediatric Gastroenterology and Nutrition, Pediatric Diabetes, PlosONe, Stem Cells; Stem Cell Research; Deutsche Forschungsgemeinschaft, Diabetes UK Foundation, Fond zur Förderung der wissenschaftlichen Forschung (FWF Österreich), French National Research Agency, Israel-Science Foundation, Bundesgesundheitsblatt

 

 

Patents

Patent Number: DE 102 61 125 A1:Verfahren zur Herstellung von Stammzellen aus Pankreas
Appl. Number: 13/659,523: Pancreatic islet of transgenic LEA29Y animals for treating diabetes (pending)